openPR Logo
Press release

Global Cell and Gene Therapy Market worth US$ 1.8 billion 2019 with a CAGR of 35.60%

03-31-2021 02:35 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Prophecy Market Insights

Global Cell and Gene Therapy Market worth US$ 1.8 billion 2019

The report "Global Cell and Gene Therapy Market, By Products (Cell Therapy, and Gene Therapy), By Distribution Channel Type (Oncology, Dermatology, Musculoskeletal, and Others), By End-Users (Hospitals, Wound Care Centers, Cancer Care Centers, Ambulatory Surgical Centers, and Others), and Region - Global Forecast to 2030" global cell and gene therapy market is projected to grow from US$ 1.8 billion in 2019. The major factor driving the global cell and gene therapy market is an increased pool of patients with various diseases, product launches and approvals. Also, favorable regulatory support and special designations for cell and gene therapy products, growing demand for car t-cell therapy products. The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include drug approvals and a strong pipeline of cell and gene therapies.
Key Highlights:

In December 2019, Kite a Gilead Company and the CIMBTR, the research collaboration between the National Marrow Donor Program, Be The Match and the Medical College of Wisconsin announced findings from an ongoing post-marketing study evaluating the safety and efficacy of Yescarta (axicabtagene ciloleucel) in adult patients with relapsed or refractory large b-cell lymphoma.
In December 2018, Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies.
Key Market Insights from the report:

The global cell and gene therapy market accounted for US$ 1.8 billion in 2019 and is projected to register a moderate CAGR of 35.60% over the forecast period. The market report has been segmented on the products, distribution channel type, end-users, and region.

By-products, gene therapy is expected to account the highest revenue share, as the penetration of these products is increasing at a significant rate.
By distribution channel type, oncology segment dominates this segment, as the available products not only modify the disease but also improve the quality of the patient's life.
By end-users, the hospital is dominating this segment, due to the increasing incidence/prevalence of chronic diseases.
By region, North America is projected to lead the global cell and gene therapy market and is expected to remain dominant during the forecast period, due to the high prevalence of chronic diseases and other conditions, which require these treatment methods.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Cell and Gene Therapy Market”, By Products (Cell Therapy, and Gene Therapy), By Distribution Channel Type (Oncology, Dermatology, Musculoskeletal, and Others), By End-Users (Hospitals, Wound Care Centers, Cancer Care Centers, Ambulatory Surgical Centers, and Others), and by Region – global forecast till 2030

Download Free sample copy of this report @

The prominent player operating in the global cell and gene therapy market includes Gilead Sciences, Spark Therapeutics, Novartis AG, Organogenesis, Amgen, Osiris Therapeutics, Dendreon, Vericel, Anterogen, Tego Sciences.


Prophecy Market Insights


About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cell and Gene Therapy Market worth US$ 1.8 billion 2019 with a CAGR of 35.60% here

News-ID: 2264265 • Views: 350

More Releases from Prophecy Market Insights

Industrial Lubricants Market Rapidly Changing Covid19 Pandemic Demand with Capit …
Global Industrial Lubricants Market accounted for US$ 64.20 billion in 2020 and is estimated to be US$ 81.78 billion by 2030 and is anticipated to register a CAGR of 2.50%. Lubricants used in heavy machineries that reduce friction and minimize wear and tear are known as industrial lubricants. Industrial lubricants are used to avoid direct metal to metal contact in machineries. Apart from this, industrial lubricants exhibit properties such as
Applications and Regional Insights during the Forecasted Period 2020-2030: Engin …
The report "Global Engineering Plastics Market, By Type (Polycarbonate, Polyamide, ABS, PET & PBT, POM, Fluoropolymers), By End-Use Industry (Automotive & Transport, Electrical & Electronics, Industrial & Machinery, Packaging, Consumer Appliances), and Region - Global Forecast to 2029". Rising acceptance and demand from construction for engendering plastic owing to its versatility, strength-to-weight ratio, durability, corrosion resistance, and so on. Also, they have a wide range of end-use Industry in the
Pandemic Impact Outlook on Theranostics Market and Latest Developments during th …
Global Theranostic Market accounted for US$ 81.40 billion in 2020 and is estimated to be US$ 468.7 billion by 2030 and is anticipated to register a CAGR of 10.40%. Theranostics is referred to the fusion of diagnostics and drug therapy. It involves nanoscience to unite diagnostic and therapeutic applications to form a single agent, allowing for diagnosis, drug delivery, and treatment response monitoring. Theranostics helps in optimizing safety, effective results,
Turmeric Market By Size, Supplier, Demand Analysis, Type, Statistics, Regions an …
The report "Global Turmeric Market, by Type (raw and Processed), by Application (Industrial, Health and Personal Care Products, Commercial, and Household), by Distribution Channel (Direct Sales and Indirect Sales), and Region - Global Forecast to 2030" Global Turmeric Market accounted for US$ 64.53 million in 2020 and is estimated to be US$ 191.94 million by 2030 and is anticipated to register a CAGR of 11.5%. . The global turmeric market

All 5 Releases

More Releases for Therapy

Cold Pain Therapy Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘Cold Pain Therapy Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. The Cold Pain Therapy Market is expected to witness growth in upcoming years due to factors such as increase in target patient population, which mostly includes patients suffering from cancer, tuberculosis and cardiovascular diseases. This market research study determines the increase in changes and the aspects which are likely to have
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
RARE 24k Therapy Creme
Introducing Rare 24k Therapy: When NSAIDS, toxic pain killers, chiropractors and heating pads aren’t giving you enough, add RARE 24K Therapy Crème to your doctor prescribed regime. A new, natural, and scientifically proven, gold skincare remedy that delivers non-toxic pain relief to people suffering with arthritis, muscle strains, or joint pain. Press Release – December 2016 SALT LAKE CITY - RARE, 24k Gold Therapy Crème offers deep therapeutic relief using newly
Injectable Targeted Therapy Market
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of
Physical Therapy Knee Exercises
Of all orthopedic problems, knee pain is probably the most common. While the causes for knee pain are many, strengthening the knee muscles through proper exercise is one of the most effective ways to protect them from pain and injury. Physical therapy knee exercises recommended by a qualified and experienced physical therapist can help restore physical strength and motion following a knee surgery or injury. These exercises help reduce recovery